JULIAN
CARRETERO ASUNCION
TITULAR DE UNIVERSIDAD
Beth Israel Deaconess Medical Center
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Beth Israel Deaconess Medical Center (2)
2018
-
PanDrugs: A novel method to prioritize anticancer drug treatments according to individual genomic data
Genome Medicine, Vol. 10, Núm. 1
2014
-
β-catenin contributes to lung tumor development induced by EGFR mutations
Cancer Research, Vol. 74, Núm. 20, pp. 5891-5902